Rangering i aksjer
#27640
Pathkey.AI Ltd is an Australian digital health firm that harnesses artificial... Pathkey.AI Ltd is an Australian digital health firm that harnesses artificial intelligence (AI) to advance clinical trials and improve the predictability of patient outcomes, particularly within Australia. The company presents a suite of AI-driven solutions: TrialKey, a sophisticated platform for simulating and optimizing trial designs to boost success rates, and TrialGen, an AI-powered utility crafted to simplify the clinical trial design process. They extend their services to a diverse clientele, encompassing biopharmaceutical companies, MedTech innovators, governmental agencies, and various healthcare organizations. Established in Sydney in 1994, the entity known today as Pathkey.AI Ltd will formally change its name from Opyl Limited in August 2025.
Handel Pathkey.AI Ltd (PKY)
Pris PKY pris med markedsverdi på B
Markedsverdi av Pathkey.AI Ltd(PKY)
Markedsverdi: $31.56M
Per August 2026 har Pathkey.AI Ltd en markedsverdi på $31.56M. Dette gjør Pathkey.AI Ltd til det 27640th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Pathkey.AI Ltd fra 1996 til 2026
PKY sammenlignet med topp 5 mest populære stocks
| Pris på PKY |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.301T
|
+16,795,329.19%
|
|
|
|
|
$4.634T
|
+14,681,986.70%
|
|
|
|
|
$4.143T
|
+13,126,644.65%
|
|
|
|
|
$3.589T
|
+11,372,576.35%
|
|
|
|
|
$2.857T
|
+9,051,941.78%
|
